Long-term risk of ischemic heart disease following Hodgkin lymphoma treatment

被引：0
|
作者：
Van Nimwegen, F. A. [1 ]
Schaapveld, M. [1 ]
Krol, A. D. G. [2 ]
Janus, C. M. P. [3 ]
Cutter, D. [4 ]
Darby, S. [5 ]
Aleman, B. M. P. [1 ]
Van Leeuwen, F. E. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Erasmus MC Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[4] Oxford Univ Hosp NHS Trust, Oxford Canc Ctr, Oxford, England
[5] Univ Oxford, Clin Trial Serv Unit, Oxford, England
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1081
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [21] Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
    Yuen-Ting Cheng
    Chun-Fung Sin
    Edmond S. K. Ma
    Stephen T. S. Lam
    Shiu-Lun Au Yeung
    Bernard M. Y. Cheung
    Hung-Fat Tse
    Kai-Hang Yiu
    Yap-Hang Chan
    Communications Medicine, 5 (1):
  • [22] Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma
    Anders W Bjerring
    Knut HB Smeland
    Thomas Stokke
    Kristina H Haugaa
    Espen Holte
    Assami Rösner
    Cecilie E Kiserud
    Thor Edvardsen
    Sebastian Imre Sarvari
    Cardio-Oncology, 10
  • [23] One heart, many long-term complications of thoracic radiotherapy for Hodgkin lymphoma
    Albu, S.
    Ionescu, A.
    Mihailescu, O.
    Popescu, B.
    Deleanu, D.
    Ginghina, C.
    Iliescu, V.
    Chioncel, O.
    Jurcut, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 178 - 178
  • [24] Association of long-term exposure to PM2.5 and survival following ischemic heart disease
    Oh, Jongmin
    Choi, Sangbum
    Han, Changwoo
    Lee, Dong-Wook
    Ha, Eunhee
    Kim, Soontae
    Bae, Hyun-Joo
    Pyun, Wook Bum
    Hong, Yun-Chul
    Lim, Youn-Hee
    ENVIRONMENTAL RESEARCH, 2023, 216
  • [25] Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma
    Oguz, Aynur
    Tayfun, Tayyar
    Citak, Elvan Caglar
    Karadeniz, Ceyda
    Tatlicioglu, Turkan
    Boyunaga, Oznur
    Bora, Huseyin
    PEDIATRIC BLOOD & CANCER, 2007, 49 (05) : 699 - 703
  • [26] Prognostication of long-term outcomes for patients with ischemic heart disease
    Umbrasiene, Jelena
    Jankauskiene, Edita
    Kupstyte, Nora
    Babarskiene, Marija Rata
    Vencloviene, Jone
    Gustiene, Olivija
    MEDICINA-LITHUANIA, 2010, 46 (10): : 700 - 706
  • [27] EFFECTS OF LONG-TERM GALLOPAMIL IN ISCHEMIC-HEART-DISEASE
    PAZZOLA, A
    TONOLO, G
    TROFFA, C
    BACCIU, S
    PARPAGLIA, PP
    PATTERI, G
    PIGA, G
    MAMELI, P
    GIRAUDI, D
    PALA, F
    MAIOLI, M
    GITTI, M
    DIGIOVANNA, F
    GLORIOSO, N
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (06): : 1030 - 1035
  • [28] Long-term outcomes for patients with Hodgkin lymphoma at increased risk of progression or relapse
    Kosydar, Samuel
    Ansell, Stephen M.
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 5 - 17
  • [29] LONG-TERM OBSIDAN TREATMENT OF ISCHEMIC-HEART-DISEASE PATIENTS WITH HIGH-RISK OF SUDDEN-DEATH
    MAZUR, NA
    OSTROVSKAYA, TP
    DOKUCHAEVA, EA
    SMIRNOVA, TM
    IVANOVA, LA
    SUMAROKOV, AB
    KULCHINSKAYA, IV
    SVET, EA
    KOTLIAROV, VV
    ILIUSHINA, IP
    VYGODIN, VA
    KARDIOLOGIYA, 1982, 22 (08) : 64 - 68
  • [30] A case of non-Hodgkin's lymphoma following long-term corticosteroid therapy for Addison's disease
    Kakiuchi, T
    Uehara, F
    Ohba, N
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1998, 42 (05) : 393 - 397
12345